These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2828340)
1. Potentiation of thyrotropin releasing hormone-induced inositol phospholipid metabolism and Ca2+ mobilization by cyclic AMP-increasing agents. Suzuki R; Takenawa T J Biochem; 1987 Sep; 102(3):447-50. PubMed ID: 2828340 [TBL] [Abstract][Full Text] [Related]
2. Regulation of GH3-cell function via adenosine A1 receptors. Inhibition of prolactin release, cyclic AMP production and inositol phosphate generation. Delahunty TM; Cronin MJ; Linden J Biochem J; 1988 Oct; 255(1):69-77. PubMed ID: 2848512 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells. Aizawa T; Hinkle PM Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848 [TBL] [Abstract][Full Text] [Related]
4. The de novo phospholipid effect of insulin is associated with increases in diacylglycerol, but not inositol phosphates or cytosolic Ca2+. Farese RV; Davis JS; Barnes DE; Standaert ML; Babischkin JS; Hock R; Rosic NK; Pollet RJ Biochem J; 1985 Oct; 231(2):269-78. PubMed ID: 3904739 [TBL] [Abstract][Full Text] [Related]
5. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production. Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Ca2+-dependent cyclic AMP accumulation and Ca2+ metabolism in intact pituitary tumor cells by modulators of prolactin production. Brostrom MA; Brostrom CO; Brotman LA; Green SS Mol Pharmacol; 1983 Mar; 23(2):399-408. PubMed ID: 6300649 [TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-releasing hormone-stimulated inositol trisphosphate formation is liable to thyrotropin-releasing hormone-induced desensitization by a calcium-dependent mechanism. Torjesen PA; Bjøro T; Ostberg BC; Haug E Mol Cell Endocrinol; 1988 Mar; 56(1-2):107-14. PubMed ID: 3131167 [TBL] [Abstract][Full Text] [Related]
8. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone. Martinez de la Escalera G; Weiner RI Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665 [TBL] [Abstract][Full Text] [Related]
9. Subsecond and second changes in inositol polyphosphates in GH4C1 cells induced by thyrotropin-releasing hormone. Tashjian AH; Heslop JP; Berridge MJ Biochem J; 1987 Apr; 243(1):305-8. PubMed ID: 3111461 [TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity. Ramsdell JS; Tashjian AH Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223 [TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells. Yajima Y; Akita Y; Saito T J Biol Chem; 1986 Feb; 261(6):2684-9. PubMed ID: 2869031 [TBL] [Abstract][Full Text] [Related]
12. Dual actions of phorbol esters on cytosolic free Ca2+ concentrations and reconstitution with ionomycin of acute thyrotropin-releasing hormone responses. Albert PR; Tashjian AH J Biol Chem; 1985 Jul; 260(15):8746-59. PubMed ID: 3160693 [TBL] [Abstract][Full Text] [Related]
13. Alpha 1-adrenergic potentiation of vasoactive intestinal peptide stimulation of rat pinealocyte adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate: evidence for a role of calcium and protein kinase-C. Chik CL; Ho AK; Klein DC Endocrinology; 1988 Feb; 122(2):702-8. PubMed ID: 2892667 [TBL] [Abstract][Full Text] [Related]
14. Receptor density determines secretory response patterns mediate by inositol lipid-derived second messengers. Comparison of thyrotropin-releasing hormone and carbamylcholine actions in thyroid-stimulating hormone-secreting mouse pituitary tumor cells. Winicov I; Gershengorn MC J Biol Chem; 1989 Jun; 264(16):9438-43. PubMed ID: 2498332 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of inositol phospholipids metabolism and calcium mobilization by cyclic AMP-increasing agents and phorbol ester in neutrophils. Kato H; Ishitoya J; Takenawa T Biochem Biophys Res Commun; 1986 Sep; 139(3):1272-8. PubMed ID: 3021152 [TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone (TRH) elevation of inositol trisphosphate and cytosolic free calcium is dependent on receptor number. Evidence for multiple rapid interactions between TRH and its receptor. Ramsdell JS; Tashjian AH J Biol Chem; 1986 Apr; 261(12):5301-6. PubMed ID: 3007496 [TBL] [Abstract][Full Text] [Related]
18. Bidirectional control of cytosolic free calcium by thyrotropin-releasing hormone in pituitary cells. Drummond AH Nature; 1985 Jun 27-Jul 3; 315(6022):752-5. PubMed ID: 3925349 [TBL] [Abstract][Full Text] [Related]
19. Acute effects of phorbol esters on receptor-mediated IP3, cAMP, and progesterone levels in rat granulosa cells. Davis JS; Weakland LL; Coffey RG; West LA Am J Physiol; 1989 Mar; 256(3 Pt 1):E368-74. PubMed ID: 2538070 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of inositol phosphate production is a late, Ca2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells. Vallar L; Vicentini LM; Meldolesi J J Biol Chem; 1988 Jul; 263(21):10127-34. PubMed ID: 2839476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]